Fund Holdings — Saturn V Capital Management LP

Total Portfolio Value:
$198.16M
Total Bought:
$41.58M
Total Sold:
$61.77M
Net Transaction:
-$20.19M
Notable People:
Xiaoying (Nmn) Tian, Douglas Kevin Edwards
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Ascendis Pharma A/SADR(ASND)198,977199,264+287$27.39M$31.06M15.67%+$3.66M
Disc Medicine, Inc.(IRON)509,406518,177+8,771$32.30M$25.72M12.98%-$6.57M
CG Oncology, Inc.(CGON)593,262577,696-15,566$17.01M$14.15M7.14%-$2.87M
Xenon Pharmaceuticals Inc.(XENE)322,470413,711+91,241$12.64M$13.88M7.00%+$1.24M
Merus N V234,637323,211+88,574$9.87M$13.60M6.87%+$3.74M
MoonLake ImmunotherapeuticsCL A(MLTX)346,111343,849-2,262$18.74M$13.43M6.78%-$5.31M
Syndax Pharmaceuticals, Inc.(SNDX)988,5281,041,280+52,752$13.07M$12.79M6.46%-$276.2K
Celcuity Inc.(CELC)1,063,7831,093,677+29,894$13.92M$11.06M5.58%-$2.87M
Cogent Biosciences, Inc.(COGT)1,498,4251,480,020-18,405$11.69M$8.87M4.47%-$2.82M
Vaxcyte, Inc.(PCVX)204,285232,295+28,010$16.72M$8.77M4.43%-$7.95M
Amylyx Pharmaceuticals, Inc.(AMLX)889,0732,426,436+1,537,363$3.36M$8.59M4.33%+$5.23M
argenx SEADR(ARGX)19,75413,862-5,892$12.15M$8.20M4.14%-$3.94M
Centessa Pharmaceuticals PlcADS0448,692+448,692$0$6.45M3.26%+$6.45M
Ocular Therapeutix, Inc.(OCUL)191,456598,191+406,735$1.64M$4.38M2.21%+$2.75M
Contineum Therapeutics, Inc.CL A(CTNM)573,022560,979-12,043$8.39M$3.92M1.98%-$4.48M
ABIVAX Société AnonymeADS(ABVX)653,071552,926-100,145$4.78M$3.46M1.74%-$1.32M
Kalvista Pharmaceuticals Inc556,489255,060-301,429$4.71M$2.94M1.49%-$1.77M
Newamsterdam Pharma Company
ORDINARY SHARES
100,000116,353+16,353$2.57M$2.38M1.20%-$188.3K
Silence Therapeutics plcADS(SLN)395,024732,463+337,439$2.72M$2.07M1.04%-$652.2K
Crinetics Pharmaceuticals In59,12559,017-108$3.02M$1.98M1.00%-$1.04M
Inozyme Pharma Inc1,374,582499,254-875,328$3.81M$454.3K0.23%-$3.35M
Cargo Therapeutics Inc1,007,6770-1,007,677$14.53M$0—-$14.53M
Cytokinetics, Incorporated(CYTK)348,3640-348,364$16.39M$0—-$16.39M
Ironwood Pharmaceuticals, Inc.CL A(IRWD)814,5330-814,533$3.61M$0—-$3.61M
MBX Biosciences, Inc.(MBX)18,0000-18,000$331.7K$0—-$331.7K
Page 1 of 1
Saturn V Capital Management LP — 13F Holdings — Q1 2025 | TickerTrail